average weight loss on retatrutide Eli Lilly just announced striking Phase 3 results for retatrutide, an experimental “triple agonist” that acts three gut-hormone targets at once. On the top dose, people lost an of 28% How Does Retatrutide Make You
Description
In recent years, this type of drug, known as a GLP-1 agonist has proven effective in diabetic control
Drug Category
How to Use
Incretins are one of the main DPP4 substrates
#DrugSafety #CounterfeitMedicine #Retatrutide
There are other drugs undergoing clinical testing to treat patients whose fibrosis is less advanced and could possibly halt the scarring or even lessen the amount of fat in the patient's liver
